Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
9823 | 1117 | 34.5 | 51% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
33 | 3 | JOURNAL OF BACTERIOLOGY//MICROBIOLOGY//MOLECULAR MICROBIOLOGY | 107033 |
910 | 2 | QUORUM SENSING//PSEUDOMONAS AERUGINOSA//N ACYL HOMOSERINE LACTONE | 11236 |
9823 | 1 | PSEUDOMONAS AERUGINOSA//PSEUDOMONAS VACCINE//RD BIOSCI | 1117 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PSEUDOMONAS AERUGINOSA | authKW | 109115 | 14% | 3% | 160 |
2 | PSEUDOMONAS VACCINE | authKW | 82006 | 0% | 100% | 3 |
3 | RD BIOSCI | address | 62477 | 0% | 57% | 4 |
4 | COMMON POLYSACCHARIDE ANTIGEN | authKW | 61503 | 0% | 75% | 3 |
5 | RECOMBINANT FLAGELLIN | authKW | 61503 | 0% | 75% | 3 |
6 | ETHANOLAMINE DIPHOSPHATE | authKW | 54671 | 0% | 100% | 2 |
7 | OPRF OPRI | authKW | 54671 | 0% | 100% | 2 |
8 | P AERUGINOSA OUTER MEMBRANE PROTEINS | authKW | 54671 | 0% | 100% | 2 |
9 | PSEUDOMONAS AERUGINOSA ANTIGENS | authKW | 54671 | 0% | 100% | 2 |
10 | PSEUDOMONAS AERUGINOSA IMMUNOLOGY | authKW | 54671 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Microbiology | 8846 | 37% | 0% | 418 |
2 | Immunology | 7816 | 40% | 0% | 451 |
3 | Infectious Diseases | 6517 | 23% | 0% | 258 |
4 | Respiratory System | 380 | 5% | 0% | 60 |
5 | Pediatrics | 246 | 6% | 0% | 68 |
6 | Medicine, Research & Experimental | 234 | 7% | 0% | 73 |
7 | Pathology | 212 | 5% | 0% | 51 |
8 | Critical Care Medicine | 125 | 2% | 0% | 27 |
9 | BIOLOGY, MISCELLANEOUS | 67 | 0% | 0% | 2 |
10 | Virology | 45 | 2% | 0% | 23 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | RD BIOSCI | 62477 | 0% | 57% | 4 |
2 | SNUH | 54671 | 0% | 100% | 2 |
3 | PNEUMONIA CLIN | 36446 | 0% | 67% | 2 |
4 | ABT PADIAT PNEUMOL NEONATOL KLIN FOR ERGRP | 27335 | 0% | 100% | 1 |
5 | ABT PADIATR PNEUMONOL NEONATAL | 27335 | 0% | 100% | 1 |
6 | BASIC TECHNOL BIOL SCI TECHNOL | 27335 | 0% | 100% | 1 |
7 | C RICORN MUCOSAL IMMUNOL | 27335 | 0% | 100% | 1 |
8 | CIC INSERM P 0801 | 27335 | 0% | 100% | 1 |
9 | CLIN PHARMACOL UNITSNUH | 27335 | 0% | 100% | 1 |
10 | CRICS NETWORK | 27335 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INFECTION AND IMMUNITY | 18722 | 12% | 1% | 135 |
2 | ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS | 5921 | 2% | 1% | 18 |
3 | FEMS MICROBIOLOGY IMMUNOLOGY | 5371 | 0% | 4% | 5 |
4 | APMIS | 5106 | 3% | 1% | 28 |
5 | ZENTRALBLATT FUR BAKTERIOLOGIE MIKROBIOLOGIE UND HYGIENE SERIES A-MEDICAL MICROBIOLOGY INFECTIOUS DISEASES VIROLOGY PARASITOLOGY | 4335 | 1% | 1% | 15 |
6 | ENRICHING COMMUNICATIONS | 3903 | 0% | 14% | 1 |
7 | FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY | 3810 | 2% | 1% | 19 |
8 | REVIEWS OF INFECTIOUS DISEASES | 3462 | 2% | 1% | 18 |
9 | JOURNAL OF MEDICAL MICROBIOLOGY | 3132 | 2% | 0% | 26 |
10 | ZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII | 2505 | 2% | 1% | 17 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SHARMA, A , KRAUSE, A , WORGALL, S , (2011) RECENT DEVELOPMENTS FOR PSEUDOMONAS VACCINES.HUMAN VACCINES. VOL. 7. ISSUE 10. P. 999 -1011 | 114 | 59% | 28 |
2 | DORING, G , PIER, GB , (2008) VACCINES AND IMMUNOTHERAPY AGAINST PSEUDOMONAS AERUGINOSA.VACCINE. VOL. 26. ISSUE 8. P. 1011 -1024 | 68 | 58% | 71 |
3 | PIER, G , (2005) APPLICATION OF VACCINE TECHNOLOGY TO PREVENTION OF PSEUDOMONAS AERUGINOSA INFECTIONS.EXPERT REVIEW OF VACCINES. VOL. 4. ISSUE 5. P. 645 -656 | 68 | 63% | 24 |
4 | KNIREL, YA , (1990) POLYSACCHARIDE ANTIGENS OF PSEUDOMONAS-AERUGINOSA.CRITICAL REVIEWS IN MICROBIOLOGY. VOL. 17. ISSUE 4. P. 273-304 | 96 | 64% | 95 |
5 | SEDLAK-WEINSTEIN, E , CRIPPS, AW , KYD, JM , FOXWELL, AR , (2005) PSEUDOMONAS AERUGINOSA: THE POTENTIAL TO IMMUNISE AGAINST INFECTION.EXPERT OPINION ON BIOLOGICAL THERAPY. VOL. 5. ISSUE 7. P. 967-982 | 76 | 51% | 16 |
6 | PIER, GB , (2007) PSEUDOMONAS AERUGINOSA LIPOPOLYSACCHARIDE: A MAJOR VIRULENCE FACTOR, INITIATOR OF INFLAMMATION AND TARGET FOR EFFECTIVE IMMUNITY.INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY. VOL. 297. ISSUE 5. P. 277-295 | 67 | 44% | 69 |
7 | MICHELIM, L , MEDEIROS, GS , ZAVASCKI, AP , (2013) CURRENT STATUS OF PSEUDOMONAS AERUGINOSA VACCINE.CURRENT PHARMACEUTICAL BIOTECHNOLOGY. VOL. 14. ISSUE 11. P. 951-959 | 49 | 57% | 2 |
8 | HOLDER, IA , (2004) PSEUDOMONAS IMMUNOTHERAPY: A HISTORICAL OVERVIEW.VACCINE. VOL. 22. ISSUE 7. P. 831-839 | 37 | 88% | 24 |
9 | HOLDER, IA , (2001) PSEUDOMONAS VACCINATION AND IMMUNOTHERAPY - AN OVERVIEW.JOURNAL OF BURN CARE & REHABILITATION. VOL. 22. ISSUE 5. P. 311-320 | 44 | 80% | 8 |
10 | PIER, GB , (2003) PROMISES AND PITFALLS OF PSEUDOMONAS AERUGINOSA LIPOPOLYSACCHARIDE AS A VACCINE ANTIGEN.CARBOHYDRATE RESEARCH. VOL. 338. ISSUE 23. P. 2549 -2556 | 40 | 80% | 24 |
Classes with closest relation at Level 1 |